Equigenetics Limited 11611234 false 2024-11-01 2025-10-31 2025-10-31 The principal activity of the company is raising of horses, biotech R&D, vet acts, acts of racehorse owners Digita Accounts Production Advanced 6.30.9574.0 true 11611234 2024-11-01 2025-10-31 11611234 2025-10-31 11611234 core:CurrentFinancialInstruments core:WithinOneYear 2025-10-31 11611234 bus:Micro-entities 2024-11-01 2025-10-31 11611234 bus:AuditExemptWithAccountantsReport 2024-11-01 2025-10-31 11611234 bus:FilletedAccounts 2024-11-01 2025-10-31 11611234 bus:SmallCompaniesRegimeForAccounts 2024-11-01 2025-10-31 11611234 bus:RegisteredOffice 2024-11-01 2025-10-31 11611234 bus:Director1 2024-11-01 2025-10-31 11611234 bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 11611234 countries:AllCountries 2024-11-01 2025-10-31 11611234 2023-11-01 2024-10-31 11611234 2024-10-31 11611234 core:CurrentFinancialInstruments core:WithinOneYear 2024-10-31 iso4217:GBP xbrli:pure

Registration number: 11611234

Equigenetics Limited
Unaudited Filleted Financial Statements
for the Year Ended 31 October 2025

Equigenetics Limited

Contents

Company Information | 1
Balance Sheet | 2 to 3
Notes to the Unaudited Financial Statements | 2

Equigenetics Limited

Company Information

Director | Dr A Clutton-Brock

Registered office | Vicarage Court 160 Ermin Street Swindon Wiltshire SN3 4NE

Accountants | Regulatory Accounting Ltd T/A Optimum Professional Services Vicarage Court 160 Ermin Street Swindon Wiltshire SN3 4NE

Equigenetics Limited

(Registration number: 11611234)
Balance Sheet as at 31 October 2025

| 2025 £ | 2024 £
Current assets | 231,550 | 233,982
Prepayments and accrued income | - | 109
Creditors: Amounts falling due within one year | (22,072) | (17,430)
Total assets less current liabilities | 209,478 | 216,661
Accruals and deferred income | (1,942) | (1,518)
| 207,536 | 215,143
Capital and reserves | 207,536 | 215,143

1 | General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
Vicarage Court
160 Ermin Street
Swindon
Wiltshire
SN3 4NE
England

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

The presentational currency of these financial statements is pound sterling and rounded to the nearest whole number.

2 | Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2024 - 1).

Equigenetics Limited

(Registration number: 11611234)
Balance Sheet as at 31 October 2025

For the financial year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 13 July 2026

......................................... Dr A Clutton-Brock Director